ofloxacin has been researched along with Leprosy, Macular in 4 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 4 (100.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Arunthathi, S; Jacob, M; Jesudasan, K; Manimozhi, N; Samuel, P; Vijayakumaran, P | 1 |
Padełskaya, EN | 1 |
Bhattacharya, SN; Jain, S; Kumar, S; Sehgal, VN | 1 |
Guglielmelli, E; Ishida, Y; Ozaki, M; Picorini, L | 1 |
1 review(s) available for ofloxacin and Leprosy, Macular
Article | Year |
---|---|
[Ofloxacin in mycobacteriosis therapy].
Topics: Animals; Anti-Infective Agents; Clinical Trials as Topic; Disease Models, Animal; Humans; Leprosy, Tuberculoid; Mice; Microbial Sensitivity Tests; Mycobacterium; Mycobacterium Infections; Ofloxacin; Topoisomerase II Inhibitors; Tuberculosis | 1997 |
1 trial(s) available for ofloxacin and Leprosy, Macular
Article | Year |
---|---|
Leucocytopenia after rifampicin and ofloxacin therapy in leprosy.
Topics: Adolescent; Adult; Aged; Double-Blind Method; Drug Therapy, Combination; Female; Humans; Leprostatic Agents; Leprosy, Borderline; Leprosy, Tuberculoid; Leukopenia; Male; Middle Aged; Ofloxacin; Rifampin | 1997 |
2 other study(ies) available for ofloxacin and Leprosy, Macular
Article | Year |
---|---|
Relapse (reactivation) in borderline tuberculoid (BT) leprosy.
Topics: Adult; Anti-Bacterial Agents; Anti-Infective Agents; Dapsone; Drug Monitoring; Granuloma; Histiocytes; Humans; Leprostatic Agents; Leprosy, Borderline; Leprosy, Tuberculoid; Lymphocytes; Male; Minocycline; Ofloxacin; Recurrence; Rifampin | 1998 |
A recurrent case of BT leprosy with widely spread skin lesions showing a histopathology of indeterminate group after 4.5-years irregular treatment, Bangladesh.
Topics: Adult; Bangladesh; Drug Therapy, Combination; Humans; Leprostatic Agents; Leprosy, Borderline; Leprosy, Tuberculoid; Male; Ofloxacin; Recurrence; Rifampin; Skin; Time Factors; Treatment Outcome; Treatment Refusal | 1999 |